Vice President, Immunology Research - Genentech Research & Early Development
Listed on 2026-09-13
-
Research/Development
Clinical Research, Research Scientist, Data Scientist, Immunology Research -
Healthcare
Clinical Research, Data Scientist
Immunology is one of Genentech/Roche’s five core therapeutic areas of focus, alongside Oncology, Cardiovascular Renal & Metabolism (CVRM), Ophthalmology and Neurology. Breakthroughs in our understanding of human disease, propelled by the development of pathobiology maps, foundational disease models and the integration of artificial intelligence combined with the rapid evolution of computationally assisted drug discovery and therapeutic modalities have unlocked unprecedented opportunities to deliver life-changing medicines for patients.
As we enter a new era of target identification and drug development, the potential to discover and develop transformative therapies has never been greater.
ROLE OVERVIEW AND KEY ACCOUNTABILITIES
The VP of Immunology Research will oversee an organization of ~70 researchers and will be responsible for the following critical accountabilities:
- Shaping and executing our Immunology research strategy to maximize impact
- Cultivate an innovative, dynamic and intellectually rigorous environment that inspires groundbreaking discoveries
- Seamless collaboration with Drug Discovery to leverage existing and explore novel drug modalities to target key pathogenic pathways underlying human disease
- Driving cross-disciplinary research at the interface of immunology and inflammation across multiple therapeutic areas, including:
- Partnering with Corporate Business Development to identify strategic external partnerships around the globe that support our strategy and strengthen the portfolio to create long-term value for the enterprise
- Collaborating with the Translational Medicine organization to deepen insights into human disease heterogeneity, enabling the discovery and development of biomarkers to guide precision medicines and identification of novel targets/pathways through ‘reverse translation’ from the clinic
- Partnering with the Center of Excellence in Computational Sciences to incorporate advanced computational approaches and artificial intelligence for novel target discovery/validation and drug discovery and development
- Advancing functional genomics efforts in collaboration with our Translational Genomics and Proteomics Center through interrogation of normal and human disease tissues and conducting large scale genomic and small molecule screens to identify novel therapeutic targets and leads, respectively
- Working with Early Clinical Development to translate novel biological insights into therapeutic strategies aimed at specific diseases and patient segments
- Represent Genentech/Roche externally at scientific conferences and meetings
- Manage budgets, resources, and timelines effectively to ensure the successful execution of research programs
- Ensure all research activities comply with relevant regulatory requirements and ethical standards
- This individual will ensure seamless cross-functional collaboration while advancing innovative science that transforms the lives of patients
The VP of Immunology Research will report to the Senior Vice President, Research-Biology in gRED Research, an independent R&D division in the Roche group. The leader will be a:
- Member of Research Review Committee
- Member of the gRED Research Leadership Team
- Ad-hoc member of the Early Stage Portfolio Team
- Ad-hoc member of teams that are formed to evaluate external innovation and business development opportunities
- Contribute to appropriate governance bodies to establish strategic directions and deliver critical objectives across the entire organization to improve efficiency and accelerate product development
LEADERSHIP OBJECTIVES FOR THIS R OLE
Team Leadership, Attracting Talent and Developing People: Fosters high-performing culture via VACC Leadership, sets clear goals and drives accountability. Breaks silos, empowers,…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).